Status:
UNKNOWN
Assessment of Serum Levels of Adenosine Deaminase and Immunoglobulin E in Patients With Chronic Spontaneous Urticaria
Lead Sponsor:
Sohag University
Conditions:
Chronic Spontaneous Urticaria
Eligibility:
All Genders
18+ years
Brief Summary
adenosine deaminase activity (ADA) has been reported to be elevated in various diseases such as psoriasis, acne and juvenile idiopathic arthritis. There is no previous studies that assessed ADA in chr...
Eligibility Criteria
Inclusion
- adult patients complaining of CSU and a group of age and sex-matched healthy controls (blood donors).
Exclusion
- Pregnancy and lactation.
- Patients with systemic diseases, especially those with autoimmune diseases and infections.
- Patients with skin diseases.
- Patients on medications such as antibiotics, nonsteroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, anticonvulsants, penicillin, and combined oral contraceptives.
Key Trial Info
Start Date :
August 15 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT05992987
Start Date
August 15 2023
End Date
March 31 2024
Last Update
August 15 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.